Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

Johnson Matthey to sell medical device components unit for $700M

Listen to the article 1 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Johnson Matthey, a U.K.-based company

March 21, 2024

Neoadjuvant pembrolizumab achieves major pathologic response in more than half of patients with resectable melanoma

In exploratory analyses of results from the SWOG S1801 trial in patients with stage III-IV resectable melanoma, researchers saw a major pathologic response in more

October 24, 2023

Fast-Acting Novel Depression Tx; Lumryz Label Expanded; GLP-1s for Addiction?

As an adjunctive treatment to antidepressants, investigational SPN-820 — a novel, first-in-class intracellular modulator of mTORC1 that was developed to provide a rapid-onset response —

October 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.